SCHEMBL5291502

SCHEMBL5291502

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)Cc3ccc(O)c(O)c3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.46
ACHE P22303 3/20 0.46
NAMPT P43490 1/20 0.39
SELP P16109 1/20 0.39
SELE P16581 1/20 0.39
NR1I2 O75469 1/20 0.38
MCHR1 Q99705 1/20 0.38
ITGB1 P05556 2/20 0.38
ITGA4 P13612 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KMT2A Q03164 1/20 0.38
NOTUM Q6P988 2/20 0.38
NR1H4 Q96RI1 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ERCC1 P07992 2/20 0.37
ERCC4 Q92889 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5295744 0.93 BCHE (0.46) BCHEACHENAMPTSELPSELE
SCHEMBL2294482 0.90 NAMPT (0.48) NAMPTNR1I2ITGB1ITGA4NPC1
SCHEMBL5289524 0.90 ITGB1 (0.44) BCHEACHEITGB1ITGA4LMNA
SCHEMBL5305927 0.90 BCHE (0.51) BCHEACHEITGB1ITGA4LMNA
SCHEMBL2298594 0.89 KMT2A (0.46) NAMPTMCHR1ITGB1ITGA4NPC1
SCHEMBL2294562 0.88 MAPT (0.44) NAMPTNR1I2ITGB1ITGA4NPC1
SCHEMBL5289381 0.88 ITGB1 (0.44) NAMPTITGB1ITGA4NPC1RAB9A
SCHEMBL2295665 0.86 PSEN1 (0.45) NAMPTITGB1ITGA4NPC1RAB9A
SCHEMBL2292763 0.85 MAPT (0.50) MCHR1RAB9ALMNASMN1; SMN2KMT2A
SCHEMBL2294711 0.85 ALDH1A1 (0.47) NAMPTLMNASMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed